|
Updates on contraception services for women at high risk of human immunodeficiency virus: World Health Organization
Saurabh Ram Bihari Lal Shrivastava1, Prateek Saurabh Shrivastava2
1 Vice - Principal Curriculum, Member of the Medical Education Unit and Institute Research Council, Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Sri Balaji Vidyapeeth – Deemed to be University, Ammapettai, Nellikuppam, Chengalpattu, Kancheepuram, Tamil Nadu, India
2 Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Sri Balaji Vidyapeeth – Deemed to be University, Ammapettai, Nellikuppam, Chengalpattu, Kancheepuram, Tamil Nadu, India
Correspondence Address:
Dr. Saurabh Ram Bihari Lal Shrivastava
Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Sri Balaji Vidyapeeth – Deemed to be University, Tiruporur - Guduvancherry Main Road, Ammapettai, Nellikuppam, Chengalpattu - 603 108, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/cmi.cmi_57_19
|
|
Use of contraception has been recommended to prevent pregnancy, practice family planning and also to prevent the acquisition of sexually transmitted infections. It is important to advocate that regardless of geographical settings, all the women should have access to the wide range of contraceptives, so that based on their preferences or values, an appropriate and well-informed choice can be made. The revised recommendation for women at high risk of HIV advocates for the use of any form of reversible contraception, including progestogen-only injectables. In conclusion, the sexual and reproductive health needs of all women are quite variable and it becomes even more challenging for the women who are either at high risk of HIV or HIV positive. The recent recommendations to expand the range of services offered, including contraceptive methods, is an important step, but will also require strengthening of the existing services.
|
